NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000014997

Registered date:29/08/2014

Rituxan injection drug use-results survey in patients with complicated nephrotic syndrome

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiednephrotic symdrome
Date of first enrollment2014/08/29
Target sample size300
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeAdverse drug reaction occurrences Relapse-free period
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaNone

Related Information

Contact

public contact
Name Shohji Kimura
Address 6-15, Otsuka 5-chome, Bunkyo-ku, Tokyo 112-8650 Japan
Telephone 03-3946-1136
E-mail Shohji_Kimura@mail.zenyaku.co.jp
Affiliation Zenyaku Kogyo, Co., Ltd. Post-Marketing-Surveillance Pharmacovigilance & Quality Assurance Department
scientific contact
Name Shohji Kimura
Address 6-15, Otsuka 5-chome, Bunkyo-ku, Tokyo 112-8650 Japan
Telephone 03-3946-1136
E-mail Shohji_Kimura@mail.zenyaku.co.jp
Affiliation Zenyaku Kogyo, Co., Ltd. Post-Marketing-Surveillance Pharmacovigilance & Quality Assurance Department